Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports

Ping Chih Hsu, Tai Di Chen, Tsung Yu Tsai, Cheng Ta Yang*

*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science